Cargando…

Dual Inhibition of EGFR and IGF-1R Signaling Leads to Enhanced Antitumor Efficacy against Esophageal Squamous Cancer

Both the epidermal growth factor receptor (EGFR) and insulin-like growth factor 1 receptor (IGF-1R) have been implicated in the development of cancers, and the increased expression of both receptors has been observed in esophageal cancer. However, the tyrosine kinase inhibitors of both receptors hav...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Jia, Guo, Zanzan, Zhang, Haoqi, Guo, Rongqi, Zhu, Xiaofei, Guo, Xiaofang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499412/ https://www.ncbi.nlm.nih.gov/pubmed/36142299 http://dx.doi.org/10.3390/ijms231810382

Ejemplares similares

Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and IGF-1R
por: Hempel, Cornelius, et al.
Publicado: (2017)

Lnc-MCEI mediated the chemosensitivity of esophageal squamous cell carcinoma via miR-6759-5p to competitively regulate IGF2
por: Liu, Guangming, et al.
Publicado: (2020)

Predictive value of EGFR overexpression and gene amplification on icotinib efficacy in patients with advanced esophageal squamous cell carcinoma
por: Wang, Xi, et al.
Publicado: (2016)

Antitumor Efficacy of EGFR-Targeted Recombinant Immunotoxin in Human Head and Neck Squamous Cell Carcinoma
por: Xie, Guiqin, et al.
Publicado: (2022)

Targeting EGFR in Combination with Nutritional Supplements on Antitumor Efficacy in a Lung Cancer Mouse Model
por: Guo, Chih-Hung, et al.
Publicado: (2022)

Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma
por: Wang, Wen-Tao, et al.
Publicado: (2019)

TRAIL-R1-Targeted CAR-T Cells Exhibit Dual Antitumor Efficacy
por: Nai, Yaru, et al.
Publicado: (2021)

Durable Response of Spinal Chordoma to Combined Inhibition of IGF-1R and EGFR
por: Aleksic, Tamara, et al.
Publicado: (2016)

Insulin activates EGFR by stimulating its interaction with IGF-1R in low-EGFR-expressing TNBC cells
por: Shin, Miyoung, et al.
Publicado: (2015)

STAT3-mediated activation of mitochondrial pathway contributes to antitumor effect of dihydrotanshinone I in esophageal squamous cell carcinoma cells
por: Qi, Ming-Ming, et al.
Publicado: (2021)

Antitumor effects and molecular mechanisms of figitumumab, a humanized monoclonal antibody to IGF-1 receptor, in esophageal carcinoma
por: Zhang, Tiehong, et al.
Publicado: (2014)

The prognostic value of EGFR overexpression and amplification in Esophageal squamous cell Carcinoma
por: Jiang, Dongxian, et al.
Publicado: (2015)

Dual EGFR and mTOR targeting in squamous cell carcinoma models, and development of early markers of efficacy
por: Jimeno, A, et al.
Publicado: (2007)

EGFR alterations in glioblastoma play a role in antitumor immunity regulation
por: Li, Xiao-Peng, et al.
Publicado: (2023)

PET Imaging Biomarkers of Anti-EGFR Immunotherapy in Esophageal Squamous Cell Carcinoma Models
por: Lee, Tae Sup, et al.
Publicado: (2018)

Co-inhibition of EGFR and IGF1R synergistically impacts therapeutically on adrenocortical carcinoma
por: Xu, Lieyu, et al.
Publicado: (2016)

PTMA binds to HMGB1 to regulate mitochondrial oxidative phosphorylation and thus affect the malignant progression of esophageal squamous cell carcinoma
por: Chen, Shaogeng, et al.
Publicado: (2023)

The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer
por: Al-Saad, Samer, et al.
Publicado: (2017)

Preclinical efficacy of Sym004, novel anti-EGFR antibody mixture, in esophageal squamous cell carcinoma cell lines
por: Fukuoka, Shota, et al.
Publicado: (2016)

Deguelin Induces Apoptosis by Targeting Both EGFR-Akt and IGF1R-Akt Pathways in Head and Neck Squamous Cell Cancer Cell Lines
por: Baba, Yuh, et al.
Publicado: (2015)

IGF1R Axis Inhibition Restores Dendritic Cell Antitumor Response in Ovarian Cancer
por: Somri-Gannam, Lina, et al.
Publicado: (2020)

Coexpression of periostin and EGFR in patients with esophageal squamous cell carcinoma and their prognostic significance
por: Jia, Wei, et al.
Publicado: (2016)

EGFR-Targeted Immunotoxin Exerts Antitumor Effects on Esophageal Cancers by Increasing ROS Accumulation and Inducing Apoptosis via Inhibition of the Nrf2-Keap1 Pathway
por: Yang, Yun, et al.
Publicado: (2018)

An EGFR/HER2-Bispecific and Enediyne-Energized Fusion Protein Shows High Efficacy against Esophageal Cancer
por: Guo, Xiao-Fang, et al.
Publicado: (2014)

MiR-99b-5p and miR-203a-3p Function as Tumor Suppressors by Targeting IGF-1R in Gastric Cancer
por: Wang, Zhenzhen, et al.
Publicado: (2018)

Proton Pump Inhibitors Enhance the Antitumor Effect of Chemotherapy for Esophageal Squamous Cell Carcinoma
por: Matsumura, Shinya, et al.
Publicado: (2022)

Intracellular Fusobacterium nucleatum infection attenuates antitumor immunity in esophageal squamous cell carcinoma
por: Li, Yiqiu, et al.
Publicado: (2023)

Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
por: Bai, Ming, et al.
Publicado: (2022)

Reduced miR-203 predicts metastasis and poor survival in esophageal carcinoma
por: He, Rongqi, et al.
Publicado: (2019)

Epigenetic alterations of the Igf2 promoter and the effect of miR-483-5p on its target gene expression in esophageal squamous cell carcinoma
por: Zhang, Han, et al.
Publicado: (2018)

miR-92a-3p promotes the proliferation, migration and invasion of esophageal squamous cell cancer by regulating PTEN
por: Li, Xin, et al.
Publicado: (2019)

Author Correction: MiR-99b-5p and miR-203a-3p Function as Tumor Suppressors by Targeting IGF-1R in Gastric Cancer
por: Wang, Zhenzhen, et al.
Publicado: (2023)

Comparison of the clinical efficacy between single-agent and dual-agent concurrent chemoradiotherapy in the treatment of unresectable esophageal squamous cell carcinoma: a multicenter retrospective analysis
por: Li, Jie, et al.
Publicado: (2018)

Identification of an IGF2BP2-Targeted Peptide for Near-Infrared Imaging of Esophageal Squamous Cell Carcinoma
por: Shu, Wenbin, et al.
Publicado: (2022)

Acquisition of EGFR TKI resistance and EMT phenotype is linked with activation of IGF1R/NF-κB pathway in EGFR-mutant NSCLC
por: Li, Ling, et al.
Publicado: (2017)

Combined treatment with metformin and gefitinib overcomes primary resistance to EGFR-TKIs with EGFR mutation via targeting IGF-1R signaling pathway
por: Pan, Yong-hong, et al.
Publicado: (2018)

The relationship between IGF2BP2 and PPARG polymorphisms and susceptibility to esophageal squamous-cell carcinomas in the eastern Chinese Han population
por: Qiu, Hao, et al.
Publicado: (2017)

miR-382 functions as a tumor suppressor against esophageal squamous cell carcinoma
por: Feng, Jie, et al.
Publicado: (2017)

Mutant TP53 G245C and R273H promote cellular malignancy in esophageal squamous cell carcinoma
por: Kang, Nan, et al.
Publicado: (2018)

A novel antitumor dithiocarbamate compound inhibits the EGFR/AKT signaling pathway and induces apoptosis in esophageal cancer cells
por: Yang, Yun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_glfto3phhdtffqlv8s5ovi06p5